BioCatalystWatch
ACRSWorkspace / ACRS / OverviewCompany library
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. (ACRS)

Website

Price
Market cap
Next catalystExpected Q1 2027ATI-052 — planned Phase 2b EoE trial · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ATI-9494

ITK × TXK

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ATI-052

TSLP × IL-4Rα

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ATI-9494

ITK × TXK

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ATI-052

TSLP × IL-4Rα

PreINDP1P3FilingApproved
Upcoming / outlook

Other pipelines

modzatinib (ATI-2138)

ITK × JAK3

PreINDP1P2P3FilingApproved
ATI-045 / bosakitug

TSLP

PreINDP1P2P3FilingApproved
modzatinib (ATI-2138)

ITK × JAK3

ATI-045 / bosakitug

TSLP

PreINDP1P2P3FilingApproved
ATI-052

TSLP × IL-4Rα

PreINDP1P2P3FilingApproved
ATI-052

TSLP × IL-4Rα

PreINDP1P2P3FilingApproved
modzatinib (ATI-2138)

ITK × JAK3

Upcoming / outlook

TSLP

PreINDP1P2P3FilingApproved

Partner / License out

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ACRS PR & News

ACRS SEC archive